GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CJ Bioscience Inc (XKRX:311690) » Definitions » EV-to-Revenue

CJ Bioscience (XKRX:311690) EV-to-Revenue : 19.79 (As of May. 06, 2025)


View and export this data going back to 2019. Start your Free Trial

What is CJ Bioscience EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CJ Bioscience's enterprise value is ₩68,616 Mil. CJ Bioscience's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was ₩3,467 Mil. Therefore, CJ Bioscience's EV-to-Revenue for today is 19.79.

The historical rank and industry rank for CJ Bioscience's EV-to-Revenue or its related term are showing as below:

XKRX:311690' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.47   Med: 28.3   Max: 56.4
Current: 19.79

During the past 7 years, the highest EV-to-Revenue of CJ Bioscience was 56.40. The lowest was 4.47. And the median was 28.30.

XKRX:311690's EV-to-Revenue is ranked worse than
69.94% of 988 companies
in the Biotechnology industry
Industry Median: 7.06 vs XKRX:311690: 19.79

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-06), CJ Bioscience's stock price is ₩10300.00. CJ Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₩373.61. Therefore, CJ Bioscience's PS Ratio for today is 27.57.


CJ Bioscience EV-to-Revenue Historical Data

The historical data trend for CJ Bioscience's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CJ Bioscience EV-to-Revenue Chart

CJ Bioscience Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial 36.86 52.68 36.85 21.45 19.00

CJ Bioscience Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.45 23.69 14.95 19.14 19.00

Competitive Comparison of CJ Bioscience's EV-to-Revenue

For the Biotechnology subindustry, CJ Bioscience's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CJ Bioscience's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CJ Bioscience's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where CJ Bioscience's EV-to-Revenue falls into.


;
;

CJ Bioscience EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

CJ Bioscience's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=68616.145/3466.537
=19.79

CJ Bioscience's current Enterprise Value is ₩68,616 Mil.
CJ Bioscience's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,467 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CJ Bioscience  (XKRX:311690) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

CJ Bioscience's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=10300.00/373.605
=27.57

CJ Bioscience's share price for today is ₩10300.00.
CJ Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩373.61.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CJ Bioscience EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of CJ Bioscience's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CJ Bioscience Business Description

Traded in Other Exchanges
N/A
Address
7th floor, Grand Central Building B, 14 Sejong-Daero, Jung-gu, Seoul, KOR
CJ Bioscience Inc is engaged in directing a healthy life based on microbiological research. It presents directions and solutions to all fields of research on the microbiome, such as academia in the bioinformatics field, R&D centers of hospitals and research institutes, and NGS (next-generation sequencing) service companies. Its services includes NGS, EZBioCloud, Healthcare among others.

CJ Bioscience Headlines

No Headlines